6 news items
Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations
FMS
12 Jun 24
, regulatory approvals, impacts related to the COVID-19 pandemic results of clinical studies, foreign exchange rate fluctuations, uncertainties
Moody's and S&P change Fresenius Medical Care's rating outlook to stable
FMS
23 May 24
, impacts related to the COVID-19 pandemic results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
FMS
21 May 24
, economic and competitive conditions, legal changes, regulatory approvals, impacts related to the COVID-19 pandemic results of clinical studies
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
BAX
DVA
FMS
17 May 24
Medical Care, where the company still retains a 32% stake.
Fresenius Medical Care faced significant challenges during the COVID-19 pandemic
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets
FMS
16 May 24
, and competitive situation, changes in laws, regulatory approvals, the impact of the Covid-19 pandemic, results of clinical studies, exchange rate
g3pipsmuwo6l3dbp6p10
FMS
7 May 24
to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, impacts related to the COVID-19 pandemic results
- Prev
- 1
- Next